Algert Global’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Algert Global’s Portfolio RXDX Stock Details RXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-7,220	Closed	-$775K	–	1326
2023 Q1	$775K	Buy	+7,220	New	+$831K	0.04%	724

Other funds holding RXDX

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Algert Global's RXDX Position: Q2 2023 in Review

Algert Global sold out of Prometheus Biosciences, Inc. Common Stock (RXDX) in Q2 2023, closing a stake of 7,220 shares — an estimated $775K sold.

Algert Global first reported a position in RXDX in Q1 2023 and held it in 1 quarter. The position peaked at $775K in Q1 2023. 2 funds tracked by Wall St. Rank hold RXDX as of Q2 2023.

Algert Global reported no remaining Prometheus Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Algert Global sold 7,220 Prometheus Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $775K.
Algert Global first reported a position in Prometheus Biosciences, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
Algert Global's Prometheus Biosciences, Inc. Common Stock position peaked at $775K in Q1 2023.
2 funds tracked by Wall St. Rank held Prometheus Biosciences, Inc. Common Stock as of Q2 2023.

Based on Algert Global's 13F filing for Q2 2023, filed 14 Aug 2023.